HEART FAILURE: A Companion to Braunwald`s Heart Disease, 3rd Edition.

Детайлно описание:
ISBN: 9781455772377
Автор: Douglas L. Mann, Michael G. Felker
Издател:http://knigomania.bg/catalogsearch/result/?q=Saunders
Година на издаване: 2015
Обем: 874 стр.
Тип корица:твърда

Особености:
Lead editor of Braunwald's Heart Disease, Dr. Douglas L. Mann, and nationally and internationally recognized heart failure expert Dr. G. Michael Felker, bring youthe latest, definitive state-of-the art information on heart failure in this outstandingBraunwald's companion volume. Heart Failure, 3rd Edition, keeps you current with recent developments in the field, improved patient management strategies, and new drug therapies and implantable devices that will make a difference in your patients' lives and in your practice. Braunwald's Heart Failure Companion also has an on-line version that is updated with late-breaking clinical trials, "Hot Off the Press" commentary and Focused Reviews that are relevant to heart failure.
Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability. Compatible with Kindle®, nook®, and other popular devices.
Use this Braunwald's companion as the definitive source to prepare for the ABIM's new Heart Failure board exam.
Access the fully searchable contents of the book online at expertconsult.com.
This edition includes 67 new authors, who are experts in the field of heart failure
Stay on the cutting edge with new chapters on:
The latest practice guidelines for medical and device therapy
Hemodynamic assessment of heart failure
Contemporary medical therapy for heart failure patients with reduced and preserved ejection fraction
Biomarkers in heart failure
Pulmonary hypertension
Management of co-morbidities in heart failure
Mechanical cardiac support devices
Get up to speed with the latest clinical trials, as well as how they have influenced current practice guidelines
Explore what's changing in key areas such as basic mechanisms of heart failure, genetic screening, cell and gene therapies, pulmonary hypertension, heart failure prevention, co-morbid conditions, telemedicine/remote monitoring, and palliative ca